Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase

F. Ogushi, R. C. Hubbard, G. A. Fells, M. A. Casolaro, D. T. Curiel, M. L. Brantly, Ronald Crystal

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

S-type α1-antitrypsin (α1AT) is a deficiency haplotype that differs from the common normal M1 (val213) α1AT haplotype by a single amino acid (glu264 to val264). To evaluate the adequacy of the antineutrophil elastase production associated wtih the S homozygous state, α1AT plasma and lung epithelial lining fluid (ELF) levels and antineutrophil elastase function were analyzed in 9 PiSS subjects. The plasma α1AT levels of SS subjects were intermediate between that of M1M1 and ZZ subjects (p < 0.001, all comparisons), and the plasma neutrophil elastase inhibitory capacity paralleled the differences in α1AT concentration (p < 0.001, all comparisons). The association rate constant for neutrophil elastase of the purified S protein was less than that of the normal molecule (S-type, 7.1 ± 0.1 x 106 M-1 s-1; M1-type, 9.6 ± 0.2 x 106 M-1 s-1; p < 0.001), but much greater than that for the Z molecule (p < 0.001). Exposure of the purified S protein to increasing oxidant burdens resulted in a dose-dependent reduction in the ability of the molecule to inhibit neutrophil elastase in a fashion parallel to that of the M1 and Z proteins. Quantification of ELF α1AT levels and antineutrophil elastase capacity demonstrated that the SS ELF parameters were, as in plasma, intermediate between M1 homozygotes and Z homozygotes. Using the association rate constant together with the quantification of ELF α1AT levels, the 'in vivo lung inhibition time' was estimated, yielding an assessment of the relative antineutrophil elastase screen of the PiSS lower respiratory tract. Interestingly, while the in vivo inhibition time of S molecules is longer than that of M1 homozygotes, it is not nearly as long as that of the Z homozygotes, consistent with the knowledge that the S homozygous state does not confer an increased risk of emphysema to the affected person.

Original languageEnglish
Pages (from-to)364-370
Number of pages7
JournalAmerican Review of Respiratory Disease
Volume137
Issue number2
DOIs
Publication statusPublished - 1 Jan 1988
Externally publishedYes

Fingerprint

Secretory Proteinase Inhibitory Proteins
Pancreatic Elastase
Homozygote
Leukocyte Elastase
Protein S
Haplotypes
Lung
Emphysema
Oxidants
Respiratory System
Amino Acids
In Vitro Techniques
S variant alpha 1-antitrypsin

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase. / Ogushi, F.; Hubbard, R. C.; Fells, G. A.; Casolaro, M. A.; Curiel, D. T.; Brantly, M. L.; Crystal, Ronald.

In: American Review of Respiratory Disease, Vol. 137, No. 2, 01.01.1988, p. 364-370.

Research output: Contribution to journalArticle

Ogushi, F. ; Hubbard, R. C. ; Fells, G. A. ; Casolaro, M. A. ; Curiel, D. T. ; Brantly, M. L. ; Crystal, Ronald. / Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase. In: American Review of Respiratory Disease. 1988 ; Vol. 137, No. 2. pp. 364-370.
@article{4e0b3aaa05f64395a8699a6c7bfeafdc,
title = "Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase",
abstract = "S-type α1-antitrypsin (α1AT) is a deficiency haplotype that differs from the common normal M1 (val213) α1AT haplotype by a single amino acid (glu264 to val264). To evaluate the adequacy of the antineutrophil elastase production associated wtih the S homozygous state, α1AT plasma and lung epithelial lining fluid (ELF) levels and antineutrophil elastase function were analyzed in 9 PiSS subjects. The plasma α1AT levels of SS subjects were intermediate between that of M1M1 and ZZ subjects (p < 0.001, all comparisons), and the plasma neutrophil elastase inhibitory capacity paralleled the differences in α1AT concentration (p < 0.001, all comparisons). The association rate constant for neutrophil elastase of the purified S protein was less than that of the normal molecule (S-type, 7.1 ± 0.1 x 106 M-1 s-1; M1-type, 9.6 ± 0.2 x 106 M-1 s-1; p < 0.001), but much greater than that for the Z molecule (p < 0.001). Exposure of the purified S protein to increasing oxidant burdens resulted in a dose-dependent reduction in the ability of the molecule to inhibit neutrophil elastase in a fashion parallel to that of the M1 and Z proteins. Quantification of ELF α1AT levels and antineutrophil elastase capacity demonstrated that the SS ELF parameters were, as in plasma, intermediate between M1 homozygotes and Z homozygotes. Using the association rate constant together with the quantification of ELF α1AT levels, the 'in vivo lung inhibition time' was estimated, yielding an assessment of the relative antineutrophil elastase screen of the PiSS lower respiratory tract. Interestingly, while the in vivo inhibition time of S molecules is longer than that of M1 homozygotes, it is not nearly as long as that of the Z homozygotes, consistent with the knowledge that the S homozygous state does not confer an increased risk of emphysema to the affected person.",
author = "F. Ogushi and Hubbard, {R. C.} and Fells, {G. A.} and Casolaro, {M. A.} and Curiel, {D. T.} and Brantly, {M. L.} and Ronald Crystal",
year = "1988",
month = "1",
day = "1",
doi = "10.1164/ajrccm/137.2.364",
language = "English",
volume = "137",
pages = "364--370",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase

AU - Ogushi, F.

AU - Hubbard, R. C.

AU - Fells, G. A.

AU - Casolaro, M. A.

AU - Curiel, D. T.

AU - Brantly, M. L.

AU - Crystal, Ronald

PY - 1988/1/1

Y1 - 1988/1/1

N2 - S-type α1-antitrypsin (α1AT) is a deficiency haplotype that differs from the common normal M1 (val213) α1AT haplotype by a single amino acid (glu264 to val264). To evaluate the adequacy of the antineutrophil elastase production associated wtih the S homozygous state, α1AT plasma and lung epithelial lining fluid (ELF) levels and antineutrophil elastase function were analyzed in 9 PiSS subjects. The plasma α1AT levels of SS subjects were intermediate between that of M1M1 and ZZ subjects (p < 0.001, all comparisons), and the plasma neutrophil elastase inhibitory capacity paralleled the differences in α1AT concentration (p < 0.001, all comparisons). The association rate constant for neutrophil elastase of the purified S protein was less than that of the normal molecule (S-type, 7.1 ± 0.1 x 106 M-1 s-1; M1-type, 9.6 ± 0.2 x 106 M-1 s-1; p < 0.001), but much greater than that for the Z molecule (p < 0.001). Exposure of the purified S protein to increasing oxidant burdens resulted in a dose-dependent reduction in the ability of the molecule to inhibit neutrophil elastase in a fashion parallel to that of the M1 and Z proteins. Quantification of ELF α1AT levels and antineutrophil elastase capacity demonstrated that the SS ELF parameters were, as in plasma, intermediate between M1 homozygotes and Z homozygotes. Using the association rate constant together with the quantification of ELF α1AT levels, the 'in vivo lung inhibition time' was estimated, yielding an assessment of the relative antineutrophil elastase screen of the PiSS lower respiratory tract. Interestingly, while the in vivo inhibition time of S molecules is longer than that of M1 homozygotes, it is not nearly as long as that of the Z homozygotes, consistent with the knowledge that the S homozygous state does not confer an increased risk of emphysema to the affected person.

AB - S-type α1-antitrypsin (α1AT) is a deficiency haplotype that differs from the common normal M1 (val213) α1AT haplotype by a single amino acid (glu264 to val264). To evaluate the adequacy of the antineutrophil elastase production associated wtih the S homozygous state, α1AT plasma and lung epithelial lining fluid (ELF) levels and antineutrophil elastase function were analyzed in 9 PiSS subjects. The plasma α1AT levels of SS subjects were intermediate between that of M1M1 and ZZ subjects (p < 0.001, all comparisons), and the plasma neutrophil elastase inhibitory capacity paralleled the differences in α1AT concentration (p < 0.001, all comparisons). The association rate constant for neutrophil elastase of the purified S protein was less than that of the normal molecule (S-type, 7.1 ± 0.1 x 106 M-1 s-1; M1-type, 9.6 ± 0.2 x 106 M-1 s-1; p < 0.001), but much greater than that for the Z molecule (p < 0.001). Exposure of the purified S protein to increasing oxidant burdens resulted in a dose-dependent reduction in the ability of the molecule to inhibit neutrophil elastase in a fashion parallel to that of the M1 and Z proteins. Quantification of ELF α1AT levels and antineutrophil elastase capacity demonstrated that the SS ELF parameters were, as in plasma, intermediate between M1 homozygotes and Z homozygotes. Using the association rate constant together with the quantification of ELF α1AT levels, the 'in vivo lung inhibition time' was estimated, yielding an assessment of the relative antineutrophil elastase screen of the PiSS lower respiratory tract. Interestingly, while the in vivo inhibition time of S molecules is longer than that of M1 homozygotes, it is not nearly as long as that of the Z homozygotes, consistent with the knowledge that the S homozygous state does not confer an increased risk of emphysema to the affected person.

UR - http://www.scopus.com/inward/record.url?scp=0023861041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023861041&partnerID=8YFLogxK

U2 - 10.1164/ajrccm/137.2.364

DO - 10.1164/ajrccm/137.2.364

M3 - Article

C2 - 3257660

AN - SCOPUS:0023861041

VL - 137

SP - 364

EP - 370

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 2

ER -